Holocene Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Holocene Advisors's DGX Position: Q4 2024 in Review
Holocene Advisors sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 10,161 shares — an estimated $1.58M sold.
Holocene Advisors first reported a position in DGX in Q1 2018 and held it in 11 quarters. The position peaked at $8.59M in Q4 2023. 895 funds tracked by Wall St. Rank hold DGX as of Q4 2024.
- Holocene Advisors reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
- Holocene Advisors sold 10,161 Quest Diagnostics shares in Q4 2024, an estimated $1.58M.
- Holocene Advisors first reported a position in Quest Diagnostics in Q1 2018 and held it in 11 quarters.
- Holocene Advisors's Quest Diagnostics position peaked at $8.59M in Q4 2023.
- 895 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.
Based on Holocene Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.